img-fgs-transforming-drug-discovery1920x640
Whitepaper

How CRISPR-based functional genomics is transforming drug discovery

A key challenge in disease research is the ability to assign functional characteristics from genomic sequences. With functional genomics you can gain valuable insights into the relationships between genotypes and phenotypes using large-scale data from genome-wide omics-based experiments.

Here, we discuss how CRISPR-based technologies and functional genomic screening are being applied to the field of drug discovery across multiple stages of the pipeline, from target identification to patient stratification and mechanism of action studies.

Learn more about:

  • Moving from RNAi to CRISPR screens
  • Improving target identification
  • Understanding drug response mechanisms
  • Moving from in vitro to in vivo

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

How CRISPR-based functional genomics is transforming drug discovery

Download Whitepaper